PRESS RELEASE published on 11/12/2024 at 14:46, 11 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: Balanced Commercial Property Trust Limited The Vanguard Group, Inc. discloses 4.48% ownership in Balanced Commercial Property Trust Limited as of Nov 11, 2024, including purchases and sales of 1p ordinary shares Vanguard Group Ownership Disclosure Balanced Commercial Property Trust Limited Purchases And Sales Nov 11 2024
BRIEF published on 11/12/2024 at 14:44, 11 days 6 hours ago The Vanguard Group Discloses Position in SEGRO plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure SEGRO PLC
PRESS RELEASE published on 11/12/2024 at 14:44, 11 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc The Vanguard Group, Inc. discloses a 3.94% stake in TI Fluid Systems plc. Purchase and sale details included in Form 8.3 Form 8.3 Disclosure The Vanguard Group Stake TI Fluid Systems Plc
BRIEF published on 11/12/2024 at 14:43, 11 days 6 hours ago The Vanguard Group's Securities Disclosure on Hargreaves Lansdown Financial Transactions Takeover Code Securities Disclosure Vanguard Group Hargreaves Lansdown
PRESS RELEASE published on 11/12/2024 at 14:43, 11 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc The Vanguard Group, Inc. discloses 4.06% stake in AngloGold Ashanti plc. Open position disclosure under Rule 8.3 of Takeover Code The Vanguard Group, Inc. Rule 8.3 Takeover Code Stake Disclosure AngloGold Ashanti Plc
PRESS RELEASE published on 11/12/2024 at 14:42, 11 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The The Vanguard Group, Inc. discloses a 1.90% stake in PRS REIT plc. Sale of 1p ordinary shares reported at 1.08 GBP per unit. No further dealings disclosed Vanguard Group Inc. Sale 1p Ordinary Shares PRS REIT Plc 1.90% Stake
BRIEF published on 11/12/2024 at 14:41, 11 days 6 hours ago The Vanguard Group Discloses Position in Smith (DS) plc Disclosure Takeover Code Vanguard Group Shareholding Smith (DS) Plc
BRIEF published on 11/12/2024 at 14:40, 11 days 6 hours ago The Vanguard Group Declares Stake in Spirent Communications Takeover Code Vanguard Group Financial Disclosure Shareholding Spirent Communications
PRESS RELEASE published on 11/12/2024 at 14:39, 11 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses 5.16% ownership in SEGRO plc. Details revealed as per Rule 8.3 of the Takeover Code Rule 8.3 Vanguard Group Inc. Takeover Code Ownership Disclosure SEGRO PLC
PRESS RELEASE published on 11/12/2024 at 14:38, 11 days 6 hours ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. discloses a 3.94% ownership in Hargreaves Lansdown plc on 12-Nov-2024 Vanguard Group Ownership Disclosure Stock Market Financial Hargreaves Lansdown Plc
Published on 11/22/2024 at 23:55, 21 hours 9 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 21 hours 34 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 21 hours 59 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 22 hours 34 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 2 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 3 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 4 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 14 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 1 hour ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 3 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 3 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
